coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    The Bridge PCN, Rochdale (LAD) · Health Inequalities Profile

    PCN U89776 · NHS Greater Manchester Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    22,507

    Registered population

    62.7% aged 18–64

    10.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    97.2%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~15,824

    Core20 residents (est.)

    Resident basis; registered basis ~22,012 · see page 3

    2,693

    Hypertension register

    +5.89% in 3 yrs · England +5.60%

    297

    SMI register

    9.5% of Rochdale (LAD)'s

    402

    COPD register

    Reviews +9.86% in 3 yrs

    Forecast to 2030

    2,971

    Hypertension patients, 2030

    +278 on today

    80.7%

    QRISK ≥20% on statins, 2030

    +1.37pp over 3 yrs

    2.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -8.6%
    Learning disability register fell over three years.

    Recorded learning disability prevalence changed by -8.6% over 2023 to 2025 (Rochdale -15.8%, ICB +1.1%, England +5.4%), which could reflect unverified coding changes.

    59.5%
    Breast and cervical screening trail benchmarks.

    Breast screening is 59.5% (Rochdale 69.0%, ICB 68.8%, England 69.9%) and cervical screening is 62.6% (England 66.8%), which may reflect unverified access barriers.

    77.8%
    Lipid therapy and SMI checks exceed England.

    Lipid-lowering therapy for QRISK ≥ 20% reaches 77.8% (Rochdale 68.3%, ICB 67.0%, England 63.6%), and SMI blood pressure checks reach 86.3% (England 83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A young population with 10.1% aged 65+ may explain low crude dementia prevalence

    The Bridge PCN has a markedly young registered list of 22,507 patients: 27.2% (6,131) are aged 0-17, compared with 23.5% in Rochdale, 21.8% in NHS Greater Manchester ICB and 19.6% in England. Conversely, only 10.1% (2,261) are aged 65+, below Rochdale (14.7%), NHS Greater Manchester ICB (14.9%) and England (17.9%). The 18-64 cohort accounts for 62.7% (14,115). Census estimates record 0.1% Gypsy or Irish Traveller and 0.1% Roma. Lower crude dementia prevalence of 0.4% (102 patients; Rochdale 0.8%, England 0.8%) is consistent with this young structure, though benchmark scenarios indicate an unadjusted 74-patient gap.

    Age profile

    0–1727.2%
    18–6462.7%
    65+10.1%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Rochdale (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Rochdale LA)2,3002,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)74.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Rochdale LA)1,0881,0219552024/25
    Falls deaths, all ages, per 100,000 (Rochdale LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 covers 97.2% of registered patients, spanning from 92.1% to 100.0% across practices

    Average IMD decile is 1.8 (Rochdale 3.6, England 5.5). Core20 quintile 1 covers 97.2% of registered patients, exceeding Rochdale (48.0%) and England (21.0%). Across practices, Core20 shares span a 7.9 pp range: Dr Gwd Bhima is 100.0% and Family Practice is 92.1%. Estimated resident Core20 population is 15,824, whereas practice estimates sum to 22,012 registered patients on different denominator bases. Reconciling registered patient lists with resident small-area counts is required before deploying targeted outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Dr Gwd Bhima100.0% · 1,909 patients
    Croft Shifa100.0% · 7,461 patients
    Dale Medical100.0% · 2,336 patients
    Dr Mb Ghafoor &97.6% · 6,313 patients
    Family Practice92.1% · 3,993 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    297

    SMI register

    1.29% recorded prevalence

    147

    Learning disability register

    0.64% recorded prevalence

    11

    Care homes, 262 beds

    In the PCN catchment

    9.7%

    Provide unpaid care

    Rochdale (LAD), Census 2021

    Severe mental illness recorded prevalence is 1.3% (297 patients), above Rochdale (1.2%) and England (1.0%). Learning disability prevalence is 0.6% (147 patients; Rochdale 0.7%, England 0.6%). The PCN catchment contains 11 care homes with 262 beds; bed capacity does not establish resident occupancy. Higher severe mental illness prevalence makes maintaining annual health check coverage a workload priority.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.3% (England 1.0%). Annual checks reach 86.3% for blood pressure and 85.4% for BMI (England 83.4% and 82.1%). However, blood pressure review completion is 78.8% at Croft Shifa Health Centre.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    2,693

    Hypertension register

    +5.89%

    Register growth, 3 yrs

    Rochdale (LAD) +6.17% · England +5.60%

    +6.90pp

    BP control, under 80

    ≤140/90 · −0.27pp aged 80+

    +278

    More patients by 2030

    Forecast 2,971 (13.12%)

    Hypertension case-finding and control

    Hypertension prevalence is 11.7% (2,693 patients), compared with England (15.2%), Rochdale (15.6%) and NHS Greater Manchester Integrated Care Board (14.4%). Hypertensive patients treated to target improved +15.1% over 2023 to 2025 (England +3.6%), with current control at 67.9% (England 70.3%, Rochdale 70.5%). Recent blood pressure checks reached 87.3% (England 90.0%). For patients aged 80 and over, blood pressure control is 81.1% (England 81.2%), changing -0.3% over 2023 to 2025 (England +2.2%). With blood pressure recording and older-adult control trailing national benchmarks, systematic recall for patients aged 80 and over could improve management.

    Lipids and statins

    Lipid-lowering therapy uptake in QRISK ≥ 20% reaches 77.8%, exceeding Rochdale (68.3%), NHS Greater Manchester Integrated Care Board (67.0%) and England (63.6%). For patients with diabetes aged 40 and over without cardiovascular disease, statin treatment is 83.8% (England 73.2%, Rochdale 76.6%). Prescribing exceeds comparators across both cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202647,839£2.00£1.94£1.86£95,678
    Cardiovascular (all), 202551,933£3.02£3.15£3.33£156,838

    In 2026, the PCN prescribed 47,839 items for lipid-regulating drugs at £2.00 per item (England £1.86, Rochdale £2.08, NHS Greater Manchester Integrated Care Board £1.94), spending £6,697 more than at England's unit cost across 47,839 items. Total spend was £95,678. Unit cost is a cost indicator rather than an efficiency target.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +17.92%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.43%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence changed +20.0% over 2023 to 2025 (England +2.6%) to 1.8% (402 patients), with 78.6% reviewed (England 76.4%), leaving an unadjusted register gap range of +24 to +183 patients. Asthma prevalence is 6.8% (1,447 patients; England 6.6%) with 68.2% reviewed (England 65.7%), leaving about 460 patients without a recorded review. Second-hand smoke recording for ages 6-19 reaches 87.8% (296 patients; England 78.8%). Asthma prescribing for ages 5-19 is 1,262 items per 1,000 (Rochdale 1,888, England 1,488).

    Cancer register and children's immunisation

    Cancer prevalence is 2.0% (455 patients), below England (3.8%) and Rochdale (3.6%). In Q1 2025/26, 12-month 6-in-1 coverage was 97.3% (95.0% target). However, 24-month MMR dose 1 (92.0%) and age-5 4-in-1 booster (92.0%) trail target by 3 pp, with age-5 MMR dose 2 at 93.3%. Closing pre-school immunization gaps requires targeted recall.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.3%

    England 91.0%

    6-in-1 complete primary course at 24 months94.7%

    England 92.2%

    MMR dose 1 at 24 months92.0%

    England 88.3%

    MMR dose 2 at age 593.3%

    England 82.8%

    4-in-1 pre-school booster at age 592.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In NHS Greater Manchester ICB (2022), 55.6% of staged cancers (6,491 of 11,679 with known stage; 70.8% known-stage share) were diagnosed at stage 1 or 2, in line with England (55.3%) but 19.4 pp below the 75.0% national ambition, representing 2,268.2 extra cases. ICB staging reflects wider system data, not PCN performance, and is subject to known-stage coverage. In primary care, PCN cervical screening coverage is 62.6% (England 66.8%; Rochdale 68.8%), and breast screening coverage is 59.5% (England 69.9%). Lower screening uptake may delay early cancer detection, making proactive recall and targeted outreach key operational priorities.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For Northern Care Alliance NHS Foundation Trust in Jul 2026, 62-day cancer referral to treatment was 78.6% (standard 85.0%), above Manchester University NHS Foundation Trust (72.8%), NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). The 28-day faster diagnosis standard reached 75.2% (standard 75.0%), behind Manchester University NHS Foundation Trust (80.1%), the ICB (79.5%) and England (79.3%). Diagnostic 6+ week waits were 5.1% for MRI and 4.1% for CT, but 31.5% for echocardiography and 38.2% for audiology. These acute provider figures describe system pathway flow, not PCN performance.

    Pathways within standard (%)Northern Care AllianceTameside and Glossop Integrated CareManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)75.2082.4880.0679.5379.32
    31-day treatment (96%)94.5496.2592.5496.4992.50
    62-day referral to treatment (85%)78.6576.7772.8575.7371.16
    Diagnostic waits over 6 weeks (%)Northern Care AllianceTameside and Glossop Integrated CareManchesterEngland
    MRI5.090.0011.6821.40
    CT4.100.1814.669.92
    Echocardiography31.480.004.9128.48
    Colonoscopy40.041.514.5130.83
    Gastroscopy36.485.4529.3529.02
    All 15 DM01 tests15.710.808.9823.14
    Community services activityRochdale residentsGreater Manchester ICB
    Care contacts60,250573,310
    Referrals9,45594,470
    Patients with a contact19,345183,535

    Community services (residents of Rochdale), Jun 2026 (provisional). In Jun 2026 (provisional), 40.9% of community service contacts among Rochdale borough residents (24,650 of 60,250 contacts) were with adults aged 65+. While these figures capture borough-level activity rather than PCN-specific referrals, they reflect substantial community service dependency among older residents across the wider local health economy.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    Overall QOF achievement across England is 92.5%. Practice achievement across the PCN ranges from 83.3% at Croft Shifa Health Centre to 96.6% at Dr Mb Ghafoor & Partners (Family Practice achieved 93.3%). QOF vaccination achievement spans 56.7 pp, from 38.6% at The Dale Medical Practice to 95.4% at Dr Mb Ghafoor & Partners (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Dr Gwd Bhima84100.087.3%82.8%96.2%
    Family Practice12892.190.1%73.4%88.1%
    Dale Medical93100.070.7%83.9%76.5%
    Dr Mb Ghafoor &8997.652.3%86.3%67.5%
    Croft Shifa112100.024.5%72.3%44.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRochdale (LAD)AssetPCNRochdale (LAD)
    Care homes (catchment)11 (262 beds)n/aSchools (catchment)64n/a
    Children's centres717Places of worship39116
    Libraries112Primary schools (LA maintained)938
    Primary academies826Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    On the 1,447-patient asthma register, 68.2% had a review in the last 12 months (England 65.7%, Rochdale 66.2%), leaving a scale indicator of about 460 patients without a recorded review. For discussion, practices could run a single-template asthma recall offering flexible after-school or holiday slots alongside inhaler prescribing checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Age-stratified COPD case-finding search

    COPD QOF prevalence is 1.8% (402 patients) vs 2.6% in Rochdale and 1.9% in England, giving an unadjusted benchmark register gap range of +24 to +183 patients. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Learning disability register validation audit

    Learning disability QOF prevalence fell 8.6% over 2023 to 2025 (England +5.4%, ICB +1.1%, Rochdale -15.8%); current prevalence is 0.6% (147 patients), with an unadjusted benchmark gap range of -15 to +1. Moderate effort to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Age-stratified dementia audit (p2)Dementia: QOF prevalence66.7% diagnosis ambition · 95% care plan 2027PCN
    Core20 population reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI blood pressure recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older adult hypertension recall (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation call recall (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Age-stratified COPD case-finding search (p12)COPD register · COPD: QOF prevalence · Aged 65+Core20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Learning disability register validation audit (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15